The purpose of the Biologics and Biotechnology Committee is to monitor 1) new developments in veterinary biologics, 2) regulation of the manufacture, distribution and use of veterinary biologics, and 3) needs of the livestock industries for new biological products. The Committee has the responsibility of keeping abreast and advising USAHA of new biotechnology, products and regulations that may have profound economic implications on animal health. Further, the Committee provides a forum to focus on issues and developments in the field of biotechnology that are designed to provide protection to man, animals and the environment.
Resolution 26: Manufacturing of Veterinary Biologicals without Licensure
Resolution 33: UPDATING ANTIQUATED TESTING REQUIREMENTS FOR ANIMALS USED IN THE PRODUCTION OF LICENSED SERUM ANTIBODY PRODUCTS
Resolution 32: Funding for New Facility Operations at the National Centers for Animal Health
Resolution 15: Funding for the USDA—AHPIS—VS Center for Veterinary Biologics
Resolution 13: Importation of Fetal Bovine Serum
Resolution 20: USDA Jurisdiction for Animal Disease Vaccines That Also Have a Public Health Benefit